Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.980
-0.010 (-0.25%)
At close: Jan 16, 2026, 4:00 PM EST
4.029
+0.049 (1.23%)
After-hours: Jan 16, 2026, 7:59 PM EST
Prime Medicine Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$6.42
Upside
+61.31%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $5 → $4.25 | Hold | Maintains | $5 → $4.25 | +6.78% | Nov 11, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +126.13% | Nov 10, 2025 |
| Citigroup | Citigroup | Hold Maintains $1.5 → $4 | Hold | Maintains | $1.5 → $4 | +0.50% | Aug 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +151.26% | Aug 8, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $10 → $1.5 | Strong Buy → Hold | Downgrades | $10 → $1.5 | -62.31% | May 27, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +50.75% | May 20, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 20, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +201.51% | May 19, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 → $16 | Strong Buy | Maintains | $15 → $16 | +302.01% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +151.26% | Mar 19, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $10 | Buy | Reiterates | $10 | +151.26% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +151.26% | Mar 3, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +276.88% | Mar 3, 2025 |
| JMP Securities | JMP Securities | Buy Initiates $10 | Buy | Initiates | $10 | +151.26% | Dec 10, 2024 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +352.26% | Dec 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.